Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2011-7-29
pubmed:abstractText
Sustained virological response (SVR) rates in patients with hepatitis C are heterogeneous and are influenced by a wide range of host and viral factors.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1573-2568
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
56
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2449-55
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:21706207-Adolescent, pubmed-meshheading:21706207-Adult, pubmed-meshheading:21706207-Age Factors, pubmed-meshheading:21706207-Aged, pubmed-meshheading:21706207-Alanine Transaminase, pubmed-meshheading:21706207-Alcohol Drinking, pubmed-meshheading:21706207-Antiviral Agents, pubmed-meshheading:21706207-Body Mass Index, pubmed-meshheading:21706207-Drug Therapy, Combination, pubmed-meshheading:21706207-Female, pubmed-meshheading:21706207-Hepacivirus, pubmed-meshheading:21706207-Hepatitis C, Chronic, pubmed-meshheading:21706207-Humans, pubmed-meshheading:21706207-Interferon-alpha, pubmed-meshheading:21706207-Liver Cirrhosis, pubmed-meshheading:21706207-Male, pubmed-meshheading:21706207-Middle Aged, pubmed-meshheading:21706207-Polyethylene Glycols, pubmed-meshheading:21706207-RNA, Viral, pubmed-meshheading:21706207-Recombinant Proteins, pubmed-meshheading:21706207-Retrospective Studies, pubmed-meshheading:21706207-Ribavirin, pubmed-meshheading:21706207-Treatment Outcome, pubmed-meshheading:21706207-Young Adult
pubmed:year
2011
pubmed:articleTitle
Prediction of sustained virological response to combination therapy with pegylated interferon alfa and ribavirin in patients with genotype 3 chronic hepatitis C.
pubmed:affiliation
Department of Hepatology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
pubmed:publicationType
Journal Article